J3299 HCPCS code: Injection, triamcinolone acetonide (xipere), 1 mg
J3299 is the HCPCS Level II code for injection, triamcinolone acetonide (xipere), 1 mg. In 2024 Medicare paid an average of $37.68 per service for J3299 across 67,528 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 72 per day on outpatient hospital claims. Medicare volume rose 730% from 2022 to 2024 (8,138 to 67,528 services). In 2024, about 343 clinicians billed Medicare for J3299 for 1,305 beneficiaries; Texas, Pennsylvania, Arizona accounted for 42% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2022-07-01 |
| Last action effective | 2022-07-01 |
Who bills J3299 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 343 |
| Medicare beneficiaries | 1,305 |
| States with claims | 27 |
| Share of services in top 3 states (Texas, Pennsylvania, Arizona) | 42% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J3299, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 8,138 | 270 | $51.91 | $41.36 |
| 2023 | 40,182 | 847 | $46.89 | $37.33 |
| 2024 | 67,528 | 1,305 | $47.39 | $37.68 |
States with the most J3299 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Texas | 13,593 | $37.90 |
| Pennsylvania | 7,893 | $38.02 |
| Arizona | 5,625 | $37.97 |
| California | 5,625 | $37.94 |
| Florida | 4,870 | $37.64 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 72 | Anatomic Consideration |
| practitioner claims | 72 | Anatomic Consideration |
What changed for J3299
- 2022-07-01: J3299 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J3299?
J3299 is the HCPCS Level II code for injection, triamcinolone acetonide (xipere), 1 mg. Short descriptor: "Inj xipere 1 mg".
How much does Medicare pay for J3299?
In 2024, the average Medicare payment was $37.68 per service (average allowed $47.39).
Does Medicare cover J3299?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J3299 can be billed per day?
72 on outpatient hospital claims; 72 on practitioner claims (NCCI medically unlikely edits).
Related J32 codes
- J3230 — Injection, chlorpromazine hcl, up to 50 mg
- J3240 — Injection, thyrotropin alpha, 0.9 mg, provided in 1.1 mg vial
- J3241 — Injection, teprotumumab-trbw, 10 mg
- J3243 — Injection, tigecycline, 1 mg
- J3244 — Injection, tigecycline (accord), not therapeutically equivalent to j3243, 1 mg
- J3245 — Injection, tildrakizumab, 1 mg
- J3246 — Injection, tirofiban hcl, 0.25 mg
- J3247 — Injection, secukinumab, intravenous, 1 mg
- J3250 — Injection, trimethobenzamide hcl, up to 200 mg
- J3260 — Injection, tobramycin sulfate, up to 80 mg
- J3262 — Injection, tocilizumab, 1 mg
- J3263 — Injection, toripalimab-tpzi, 1 mg
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J3299
- Watch J3299 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J3299
Sources: CMS HCPCS Level II release October 2025; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.